A new Canadian-made tool, developed by a research team at Kingston Health Sciences Centre (KHSC) and Queen’s University, is ...

The findings came from analyses of two national cancer registries. ILC accounts for about 10% of all newly diagnosed breast ...

A Brazilian research team has eliminated HIV from a patient’s body for 78 consecutive weeks using only medications, without ...

Cancertrialscanada.ca will empower patients and accelerate cancer research progress TORONTO, Nov. 10, 2025 /CNW/ - The Canadian Cancer Society (CCS) and the Quebec -- Clinical Research Organization in ...

The Canadian government has announced major changes to attract international graduate students, shortly after it cut the ...

Princess Margaret Cancer Centre, part of Canada's University Health Network (UHN), has partnered with genomics company Helix ...

The net result as of September 30, 2025 improved by $1.1M compared to September 2024, following termination of a Convertible Bonds financing ...

The Global Virus Network (GVN), a coalition of leading medical virologists representing 80+ Centers of Excellence and ...

FORT LAUDERDALE, FL / ACCESS Newswire / October 28, 2025 / Sunshine Biopharma Inc. (NASDAQ:SBFM) (the "Company"), a leading pharmaceutical company focused on innovative and affordable healthcare ...

SHELTON, CT / ACCESS Newswire / October 27, 2025 / NanoViricides, Inc. (NYSE American: NNVC ) (the “Company”), a clinical stage leader developing revolutionary broad-spectrum antiviral drugs that the ...

Takeda is paying Innovent Biologics $1.2 billion upfront for rights to two cancer candidates. The deal, which includes (PDF) $10.2 billion in milestones, puts the biologics at the center of Takeda’s ...

Researchers uncover that rectal spacers significantly enhance cancer cure rates, reducing treatment failure by 50% in prostate cancer patients. Discover how rectal spacers revolutionize prostate ...